Potential applications of gene therapy in the patient with cancer.

Abstract:

:The elderly population has much to gain from the advances of molecular medicine, although at present genetic pharmacology remains mostly at the conceptual level. Cancer, in particular, is an increasing health burden and the majority (over 70%) of gene therapy trials are aimed at tackling this problem. Available strategies employ both viral and synthetic vectors with the selective delivery and expression of therapeutic genes a pivotal requirement. Clinical trials are now in progress with a view to modulating disease at many different levels, including the direct replacement of abnormal genes. suicide-gene formulations, and the delivery of 'gain of function' genes, which seek to alter the malignant phenotype by indirect means, such as, immunopotentiation and stromal reorganisation. Early data from these studies is tantalising and we must remain optimistic that gene therapy will benefit the patient with cancer by both reducing morbidity and extending life.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Szlosarek PW,Dalgleish AG

doi

10.2165/00002512-200017020-00004

subject

Has Abstract

pub_date

2000-08-01 00:00:00

pages

121-32

issue

2

eissn

1170-229X

issn

1179-1969

journal_volume

17

pub_type

杂志文章,评审
  • Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database.

    abstract:BACKGROUND:Antidepressant medications have long been implicated as a cause of falls in older people, but there are few data on the risk of falls associated with exposure to serotonin-norepinephrine (noradrenaline) reuptake inhibitors (SNRIs). OBJECTIVE:The aim of this study was to determine the role of SNRIs in older ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11592860-000000000-00000

    authors: Gribbin J,Hubbard R,Gladman J,Smith C,Lewis S

    更新日期:2011-11-01 00:00:00

  • Vitreous haemorrhage in elderly patients: management and prevention.

    abstract::Vitreous haemorrhage can be caused by a disruption of normal retinal vessels, bleeding from diseased retinal vessels, bleeding from abnormal new vessels or extension of haemorrhage through the retina from other sources. In the elderly, vitreous haemorrhage usually occurs spontaneously and only occurs occasionally as a...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320090-00003

    authors: Manuchehri K,Kirkby G

    更新日期:2003-01-01 00:00:00

  • Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy.

    abstract:BACKGROUND:Because of co-morbidity, older persons are often exposed to use of an excessive number of drugs, which per se implies also use of inappropriate drugs or of potentially interacting drugs ('suboptimal prescribing'). Time trends of suboptimal prescribing in older, community dwellers have been poorly investigate...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11319390-000000000-00000

    authors: Lapi F,Pozzi C,Mazzaglia G,Ungar A,Fumagalli S,Marchionni N,Geppetti P,Mugelli A,Di Bari M

    更新日期:2009-01-01 00:00:00

  • Diagnostic and pharmacological approaches in Alzheimer's disease.

    abstract::Alzheimer's disease is a chronic progressive disease affecting higher intellectual functioning. The clinical diagnosis is made when the onset of illness is insidious, the course slowly progressive and all the treatable causes of dementia have been ruled out. The use of more stringent criteria has improved clinical dia...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101020-00006

    authors: Hermann C,Stern RG,Losonzcy MF,Jaff S,Davidson M

    更新日期:1991-03-01 00:00:00

  • Sleep disorders in Parkinson's disease: epidemiology and management.

    abstract::Sleep problems are an under-emphasised cause of disability in Parkinson's disease (PD) and may be seen independently of PD, associated with primary PD pathology, or as a result of antiparkinsonian medications. Common sleep disorders include excessive daytime sleepiness, rapid eye movement (REM) sleep behaviour disorde...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219100-00002

    authors: Stacy M

    更新日期:2002-01-01 00:00:00

  • Management of lipid disorders in the elderly.

    abstract::Cardiovascular disease has been inseparable from aging in developed societies and, as a result, it is the commonest cause of mortality in elderly populations. Atherosclerosis is associated with the progressive vascular accumulation of cholesterol-laden lipoproteins, and is linearly associated with the plasma level of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710060-00005

    authors: Playford DA,Watts GF

    更新日期:1997-06-01 00:00:00

  • Disease-modifying antirheumatic drugs. Potential effects in older patients.

    abstract::Disease-modifying antirheumatic drugs (DMARDs) are frequently used in rheumatoid arthritis. A number of physiological changes occur in the elderly which may modify the use of these medications. The most commonly used DMARDs are antimalarial drugs (particularly hydroxychloroquine), sulfasalazine and methotrexate. The p...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199507060-00003

    authors: Gardner G,Furst DE

    更新日期:1995-12-01 00:00:00

  • Opioids for the treatment of chronic non-cancer pain in older people.

    abstract::Chronic pain occurs in 45-85% of the geriatric population and the need to treat chronic pain is growing substantially. Unfortunately, treatment for chronic pain is not always correctly targeted, which leads to a reduced quality of life, with decreased socialization, depression, sleep disturbances, cognitive impairment...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11534670-000000000-00000

    authors: Gianni W,Ceci M,Bustacchini S,Corsonello A,Abbatecola AM,Brancati AM,Assisi A,Scuteri A,Cipriani L,Lattanzio F

    更新日期:2009-12-01 00:00:00

  • Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

    abstract::Amitriptyline is a tricyclic antidepressant agent which also has analgesic properties. Whether its analgesic effects are linked to its mood-altering activity or attributable to a discrete pharmacological action (or a combination of both) is unknown. Clinical trials demonstrate that oral amitriptyline achieves at least...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608060-00008

    authors: Bryson HM,Wilde MI

    更新日期:1996-06-01 00:00:00

  • Early detection of Parkinson's disease. Implications for treatment.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide and is characterised by cardinal clinical features and specific pathological findings. It is possible to detect PD early on in the course of the disease, and certain laboratory studies may identify preclinical stages. Based on this...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199609030-00002

    authors: Di Paola R,Uitti RJ

    更新日期:1996-09-01 00:00:00

  • Treatment of systemic fungal infections in older patients: achieving optimal outcomes.

    abstract::Systemic fungal infections are an increasing problem in older adults. For several of the endemic mycoses, this increase is the result of increased travel and leisure activities in areas endemic for these fungi. Immunosuppressive agents, care in an intensive care unit, and invasive devices all contribute to infection w...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118050-00002

    authors: Kauffman CA,Hedderwick SA

    更新日期:2001-01-01 00:00:00

  • Diagnosis and treatment of dyspepsia in the elderly.

    abstract::Although dyspeptic symptoms are very common, the vast majority of patients have modest symptoms and rarely seek medical advice. The major organic causes of dyspepsia are chronic peptic ulcer disease, gastro-oesophageal reflux disease and malignancy. Functional dyspepsia is very common. In the fit elderly patient, prom...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199507050-00003

    authors: Pound SE,Heading RC

    更新日期:1995-11-01 00:00:00

  • Is there a role for a mucosal influenza vaccine in the elderly?

    abstract::Influenza infection is an acute respiratory disease with a high morbidity and significant mortality, particularly among the elderly and individuals with chronic diseases. The majority of countries now recommend annual influenza vaccination for all people aged 65 years or older, and for those with high risk conditions....

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199915030-00001

    authors: Corrigan EM,Clancy RL

    更新日期:1999-09-01 00:00:00

  • Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

    abstract::Intracavernous alprostadil (synthetic prostaglandin E1) is a vasodilating agent which acts by relaxing the smooth muscles of the corpus cavernosum and by increasing the diameter of cavernous arteries; this leads to erection. Following intracavernous administration, alprostadil is either locally metabolised or rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608010-00009

    authors: Lea AP,Bryson HM,Balfour JA

    更新日期:1996-01-01 00:00:00

  • Antipsychotics in older patients. A safety perspective.

    abstract::Age is a major source of variation in drug response. Social, medical and physiological heterogeneity intertwines to complicate geriatric pharmacotherapy. Inappropriate and excessive use of medication may be the most significant treatable health problem in the elderly. Older people are especially sensitive to antipsych...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199506040-00006

    authors: Pollock BG,Mulsant BH

    更新日期:1995-04-01 00:00:00

  • Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study.

    abstract:INTRODUCTION:Older cancer patients are possibly at an increased risk of medication-related problems because, typically, they receive many medications during their cancer treatment, both for the cancer itself and for supportive care. OBJECTIVES:The aim of this study was to describe the number and severity of potential ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11537310-000000000-00000

    authors: Puts MT,Monette J,Girre V,Costa-Lima B,Wolfson C,Batist G,Bergman H

    更新日期:2010-07-01 00:00:00

  • Use of Medications with Anticholinergic Properties and the Long-Term Risk of Hospitalization for Falls and Fractures in the EPIC-Norfolk Longitudinal Cohort Study.

    abstract::The consumption of medications with anticholinergic activity has been suggested to result in the adverse effects of mental confusion, visual disturbance, and muscle weakness, which may lead to falls. Existing published evidence linking anticholinergic drugs with falls, however, remains weak. This study was conducted t...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-019-00731-3

    authors: Tan MP,Tan GJ,Mat S,Luben RN,Wareham NJ,Khaw KT,Myint PK

    更新日期:2020-02-01 00:00:00

  • Acute kidney injury induced by antimicrobial agents in the elderly: awareness and mitigation strategies.

    abstract::The use of antimicrobial agents has increased in recent years as treatments have diversified and resistant bacteria have appeared. With increased use of antimicrobial agents, elderly patients are prone to adverse drug reactions (ADRs) as a result of factors such as drug-drug interactions, polypharmacy, long-term use, ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-014-0232-y

    authors: Mizokami F,Mizuno T

    更新日期:2015-01-01 00:00:00

  • Extended-release oxybutynin.

    abstract::Extended-release oxybutynin (Ditropan XL) uses an osmotic system (OROS) to deliver a controlled amount of oxybutynin chloride into the gastrointestinal tract over a 24-hour period when taken once daily. Oxybutynin binds to M3 muscarinic receptors on the detrusor muscle of the bladder, preventing acetylcholinergic acti...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200016020-00008

    authors: Comer AM,Goa KL

    更新日期:2000-02-01 00:00:00

  • Correction to: Romosozumab: A Review in Postmenopausal Osteoporosis.

    abstract::Unfortunately the sections were published incorrectly in the original article. ...

    journal_title:Drugs & aging

    pub_type: 已发布勘误

    doi:10.1007/s40266-020-00807-5

    authors: Paik J,Scott LJ

    更新日期:2020-11-01 00:00:00

  • Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation.

    abstract:BACKGROUND AND OBJECTIVE:Osteoarthritis (OA) is a highly prevalent and chronic condition characterized by pain and physical disability. Currently, many treatments are available, and they primarily target pain relief. The objectives of this study were to systematically review economic evaluations for pharmaceutical mana...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-013-0062-3

    authors: Xie F,Tanvejsilp P,Campbell K,Gaebel K

    更新日期:2013-05-01 00:00:00

  • Improvement in Renal Function and Reduction in Serum Uric Acid with Intensive Statin Therapy in Older Patients: A Post Hoc Analysis of the SAGE Trial.

    abstract:BACKGROUND:Improvement in renal function and decreases in serum uric acid (SUA) have been reported following prolonged high-intensity statin (HMG-CoA reductase inhibitor) therapy. This post hoc analysis of the SAGE trial examined the effect of intensive versus less intensive statin therapy on renal function, safety, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-015-0328-z

    authors: Deedwania PC,Stone PH,Fayyad RS,Laskey RE,Wilson DJ

    更新日期:2015-12-01 00:00:00

  • Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity.

    abstract:BACKGROUND:Multimorbidity is common in older patients with heart failure (HF), complicating therapeutic management and increasing the risk of harm. OBJECTIVE:This study sought to examine the prevalence of medicines for the treatment of comorbid conditions potentially associated with harm in older people, before and af...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-019-00645-0

    authors: Caughey GE,Shakib S,Barratt JD,Roughead EE

    更新日期:2019-05-01 00:00:00

  • Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women.

    abstract::The focus of this review is hormone replacement therapy (HRT) with continuous oral 17 beta-estradiol (herein referred to as estradiol) 2 mg/day plus sequential oral dydrogesterone 10 or 20 mg/day for 14 days of each 28-day cycle. According to data from nonblind trials, this regimen relieves climacteric symptoms, prese...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711040-00006

    authors: Foster RH,Balfour JA

    更新日期:1997-10-01 00:00:00

  • New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.

    abstract::NSAIDs are a widely used class of analgesic and anti-inflammatory drugs that act by inhibiting the cyclo-oxygenase (COX) enzyme. However, because of their nonspecificity of action, use of these agents as long-term therapy for chronic pain in diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) is often d...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724060-00001

    authors: Bansal SS,Joshi A,Bansal AK

    更新日期:2007-01-01 00:00:00

  • Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

    abstract::Relaxation of the upper age limits for solid organ transplantation coupled with improvements in post-transplant survival have resulted in greater numbers of elderly patients receiving immunosuppressant drugs such as tacrolimus. Tacrolimus is a potent agent with a narrow therapeutic window and large inter- and intraind...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522070-00001

    authors: Staatz CE,Tett SE

    更新日期:2005-01-01 00:00:00

  • Multiple sclerosis in the elderly patient.

    abstract::Multiple sclerosis (MS) is an acquired inflammatory demyelinating disease of the CNS that is typically diagnosed in the second or third decade of life. It is generally believed that over the last few decades the life expectancy of patients with adult onset MS (AOMS) has approached that of the general population as a r...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11532120-000000000-00000

    authors: Awad A,Stüve O

    更新日期:2010-04-01 00:00:00

  • Nadroparin calcium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

    abstract::Nadroparin (nadroparin calcium) is a low molecular weight heparin with a mean molecular weight of 4.5 kD. Compared with unfractionated heparin (UFH), nadroparin has a greater ratio of anti-factor Xa to anti-factor Ha activity, greater bioavailability and a longer duration of action, allowing it to be administered by s...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710040-00006

    authors: Davis R,Faulds D

    更新日期:1997-04-01 00:00:00

  • Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review.

    abstract:BACKGROUND:In the presence of multimorbidity and limited life expectancy (LLE), the need for continued use of preventive medicines becomes uncertain as they may neither improve health nor confer continued health benefits. OBJECTIVE:Our objective was to systematically review the literature to examine the discontinuatio...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0487-1

    authors: Narayan SW,Nishtala PS

    更新日期:2017-10-01 00:00:00

  • Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.

    abstract:BACKGROUND AND OBJECTIVE:Multiple drug use is common among old, frail nursing home residents who are, as a consequence, susceptible to adverse effects and drug interactions. This study uses the updated Beers criteria for potentially inappropriate drug (PID) use in older adults to determine the extent and nature of PIDs...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825080-00005

    authors: Hosia-Randell HM,Muurinen SM,Pitkälä KH

    更新日期:2008-01-01 00:00:00